Strides Pharma Science reports standalone net loss of Rs 14.30 crore in the September 2018 quarter
Sales decline 6.39% to Rs 338.43 crore
Net loss of Strides Pharma Science reported to Rs 14.30 crore in the quarter ended September 2018 as against net profit of Rs 12.56 crore during the previous quarter ended September 2017. Sales declined 6.39% to Rs 338.43 crore in the quarter ended September 2018 as against Rs 361.53 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales338.43361.53 -6 OPM %-1.003.51 -PBDT5.6228.14 -80 PBT-15.619.33 PL NP-14.3012.56 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 31 2018 | 2:08 PM IST